Radioactive drug trial offers hope for advanced melanoma patients
Disease control
Recruiting now
This early-stage trial is testing a new radioactive drug for adults with advanced melanoma that has spread or cannot be removed by surgery. The main goals are to find the safest dose and see if the drug can shrink tumors. Participants receive the drug once every six weeks for up …
Phase: PHASE1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC